Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-28

Clinical Trial Update: To Evaluate the Efficacy and Safety of Minocycline Hydrochloride Foam in the Treatment of Moderate-to-severe Acne Vulgaris [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating minocycline hydrochloride foam for moderate-to-severe acne vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline hydrochloride foam (minocycline hydrochloride)

Snippet

Sponsor: Cutia Therapeutics (Shanghai) Co., Ltd | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED